ELCC 2016: Targetable immune checkpoint molecules in lung cancer - 102017

Spotlight
Video

ELCC 2016: Targetable immune checkpoint molecules in lung cancer

VJOncology has 536 videos Subscribe Here

Loading........
Description: At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 13–16 April 2016, Joseph Paul Eder, MD, from Yale University Cancer Center, New Haven, CT, discusses multiple immune checkpoint molecules, including PD-L2, gamma interferon, IDO, TIM3 LAG-3 B7H3, that may have clinical relevance for the treatment of patients with lung cancer.
Shared By : VJOncology
Posted on : 05/11/16
Added : 2 years ago



Recommended

Nothing found.

More From VJOncology

Nothing found.